However, our observations in this study suggested in BAP1 frequently altered malignancies, such as renal cancer, mesothelioma and pancreatic cancer, manipulating the expression of BAP1 have limited effect on the expression of PD-L1 of the tumor cells. This evidence concerns the gene BAP1 and renal carcinoma.